Rula A. Hajj-Ali

Rula A. Hajj-Ali

Auto-generated profile, based on publicly available information

Rula A. Hajj-Ali

Cleveland Clinic

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Journal of Autoimmunity
Verified
Journal Article
Closed access
RHRula A. Hajj-Ali
Rula A. Hajj-Ali
LCLeonard H. Calabrese
Leonard H. Calabrese

1 January 2009 in Current Opinion in Rheumatology
Verified
Journal Article
Closed access
RHRula A Hajj-Ali
Rula A Hajj-Ali
LCLeonard H Calabrese
Leonard H Calabrese
In the past decade, primary and secondary central nervous system (CNS) vasculitides have been more commonly diagnosed and recognized than previously. With the increasing awareness of these disorders, it is crucial for the treating physician to differentiate between causes of CNS vasculitis and to recognize their marked clinical and pathophysiological heterogeneity. This review focuses on the major forms of primary CNS vasculitis, as well as secondary CNS vasculitis with emphasis on their clinical findings, diagnoses, and treatment. The proposal of reversible cerebral vasoconstriction syndromes (RCVS) as a unifying concept for a group of disorders which are characterized by acute-onset severe recurrent headaches, with or without additional neurologic signs and symptoms, and prolonged but reversible vasoconstriction of the cerebral arteries, has been a major breakthrough in this field over the past decade. Recognition of this common mimic (i.e. RCVS) has allowed optimal management of a sizable group of patients previously confused with pathologically documented CNS vasculitis. Sound treatment decisions are based on accurate diagnosis. It is essential for the clinicians involved in the evaluation of patients with CNS vasculitis to be aware of its mimics especially RCVS. This article provides a comprehensive review of CNS vasculitis and its differential diagnosis. Furthermore, it touches upon workup and treatment of CNS vasculitis.

1 February 2013 in Autoimmunity Reviews
Verified
Journal Article
Closed access
RHRula A. Hajj-Ali
Rula A. Hajj-Ali
LCLeonard H. Calabrese
Leonard H. Calabrese

18 June 2015 in Cephalalgia
Verified
Journal Article
Closed access
SJSeby John
Seby John
ASAneesh B Singhal
Aneesh B Singhal
LCLeonard Calabrese
Leonard Calabrese
KUKen Uchino
Ken Uchino
THTariq Hammad
Tariq Hammad
RHRula A Hajj-Ali
Rula A Hajj-Ali
Background: Long-term outcomes of reversible cerebral vasoconstriction syndrome (RCVS) have not been systematically investigated. Methods: The following validated questionnaires were mailed to patients recruited from the RCVS registries of two academic hospitals: headache screening form, Headache Impact Test, Migraine Disability Assessment Test, Barthel Index (BI), EuroQoL (EQ-5D-5L) and Patient Health Questionnaire (PHQ-9). Results: Of the 191 patients in the registries, 109 could be contacted and 45 responded. Median follow-up time after symptom onset was 78 months. After RCVS resolution, 24 (53%) patients continued to have headache, but the majority (88%) reported improvement in its severity. Thirteen of the 24 patients with persistent headache had a history of migraine prior to RCVS diagnosis. The majority (97.5%) of respondents were functionally independent based on BI scores. EQ-5D-5L showed better scores in the domains of mobility, self-care and usual activities, as compared to pain and anxiety/depression. Patients with persistent headache had significantly higher levels of EQ-5D-5L pain scores. PHQ-9 scores revealed only one patient (3%) with severe depression. Conclusion: More than half of RCVS patients will continue to have chronic headaches of mild to moderate intensity that are distinct from the “thunderclap” headaches at RCVS onset. The vast majority regain complete functional ability. However, pain and anxiety/depression are frequent, often aggravated by concomitant chronic headaches, and may be associated with lower quality of life.

30 May 2018 in Current Rheumatology Reports
Verified
Journal Article
Closed access
PDF file
KBKevin Byram
Kevin Byram
RHRula A. Hajj-Ali
Rula A. Hajj-Ali
LCLeonard Calabrese
Leonard Calabrese

1 May 2007 in Current Treatment Options in Neurology
Verified
Journal Article
Closed access
PDF file
EMEamonn S. Molloy
Eamonn S. Molloy
RHRula A. Hajj-Ali
Rula A. Hajj-Ali